CRISPR | IIPRD

CRISPR Patent Process And Its Applicability In The Covid Era

February 26, 2022
Covid

INTRODUCTION CRISPR technology is a targeted technique that allows researchers to modify genomes with unprecedented precision, efficiency, and flexibility. This technology is at the heart of a true biotechnology revolution, with huge implications for health, agriculture, and a variety of…

ERS Genomics Licenses CRISPR-Cas9 patent and technology to Cellular Engineering Technologies

August 23, 2021
Licensing

Recently, Dublin, Ireland-based biotechnology company, ERS Genomics Limited (“ERS”), has signed a nonexclusive license agreement with Iowa-based Cellular Engineering Technologies (“CET”) to grant access to its CRISPR-Cas9 patent portfolio. The financial terms of the agreement were not disclosed. ERS was…

Kindly complete the form to download the report